Viral Vector Manufacturing Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025
Global Viral Vector Manufacturing Market is expected to grow at a CAGR of 17.6% from 2016 to 2025.The report highlights the key trends, market outlook and the global scenario of the Global Viral Vector Manufacturing Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:
ADVANCED BIOSCIENCE LABORATORIES, INC.
ADVANCED BIOTHERAPEUTICS CONSULTING
BIOGEN IDEC (NOW BIOGEN, INC.)
BOEHRINGER INGELHEIM GMBH
CELL AND GENE THERAPY CATAPULT
COBRA BIOLOGICS (SUBSIDIARY OF RECIP AB)
GENVEC INC. (SUBSIDIARY OF INTREXON CORP.)
ID PHARMA CO. LTD.
JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
PARAGON BIOSERVICES INC.
SPARK THERAPEUTICS INC.
VIGENE BIOSCIENCES INC.
Scope of the Market
Adeno-associated Viral Vectors
Other Viral Vectors
Disease Application Market
Human Disease Applications
Veterinary Disease Applications
Application Type Market
Multivalent Viral Vector Vaccines
Multipathogen Viral Vector Vaccines
Rest of the World (RoW)